Skip to content

Understanding how patients access medicines in England

Free event
This is a past event, catch up below

Medicines are a vital part of modern health care. The question of how to provide patients with access to innovative medicines, in a way that the NHS can afford, has been discussed by policy-makers, politicians and industry for many years. In 2018, The King’s Fund released a policy report discussing some of the key issues, but the situation is evolving and the National Institute for Health and Care Excellence (NICE) is currently reviewing how it appraises new medicines.  

This free online event explored the current medicines landscape and highlighted some of the key challenges to patients accessing medicines in England. The discussion included patient, industry and system perspectives on the medicines access process.

Watch on demand

Event partner

Get in touch about sponsorship and exhibition

If you would like a conversation about your business goals, and how being involved with future events can help you, please email the Partnerships team.


  • Sally Warren photo

    Sally Warren

    Director of Policy
  • Paul Catchpole photo

    Paul Catchpole

    Value and Access Director, The Association of the British Pharmaceutical Industry (ABPI)
  • Bradley Price photo

    Bradley Price

    Policy and Public Affairs Manager, Sarcoma UK
  • Dominic Pivonka photo

    Dominic Pivonka

    Head of Health Technology Assessments and Pricing, AbbVie
  • Nina Pinwill photo

    Nina Pinwill

    Head of Commercial Operations and Acting Commercial Medicines Director (due to COVID-19), NHS England and NHS Improvement

Questions from the event